D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 112 Citations 51,911 400 World Ranking 43 National Ranking 20
Medicine D-index 87 Citations 39,833 243 World Ranking 6746 National Ranking 3712

Research.com Recognitions

Awards & Achievements

1997 - ASM Award for Research in Clinical Microbiology, American Society for Microbiology

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Internal medicine
  • Bacteria

Michael A. Pfaller mostly deals with Microbiology, Fluconazole, Candida albicans, Mycosis and Corpus albicans. Fungi imperfecti, Caspofungin, Candida glabrata, Echinocandin and Drug resistance are among the areas of Microbiology where Michael A. Pfaller concentrates his study. Michael A. Pfaller has researched Candida glabrata in several fields, including Candida parapsilosis and Candida tropicalis.

His Fluconazole study combines topics from a wide range of disciplines, such as Amphotericin B, Voriconazole, Broth microdilution and Itraconazole. His work carried out in the field of Candida albicans brings together such families of science as Epidemiology and Intensive care medicine. His biological study spans a wide range of topics, including Attributable mortality, Internal medicine, Risk factor and Pediatrics.

His most cited work include:

  • Manual of clinical microbiology (13674 citations)
  • Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2991 citations)
  • Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis (1233 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Microbiology, Fluconazole, Candida albicans, Broth microdilution and Antimicrobial. His research in Antibacterial agent, Candida glabrata, Fungi imperfecti, Caspofungin and Amphotericin B are components of Microbiology. His Fluconazole research is multidisciplinary, relying on both Minimum inhibitory concentration, Itraconazole, Voriconazole and Mycosis.

In Mycosis, Michael A. Pfaller works on issues like Internal medicine, which are connected to Immunology. Michael A. Pfaller does research in Candida albicans, focusing on Corpus albicans specifically. His Broth microdilution research includes elements of Streptococcus pneumoniae, Etest and Staphylococcus aureus.

He most often published in these fields:

  • Microbiology (73.99%)
  • Fluconazole (18.89%)
  • Candida albicans (17.18%)

What were the highlights of his more recent work (between 2014-2021)?

  • Microbiology (73.99%)
  • Antimicrobial (13.62%)
  • Staphylococcus aureus (10.37%)

In recent papers he was focusing on the following fields of study:

Michael A. Pfaller mainly focuses on Microbiology, Antimicrobial, Staphylococcus aureus, Broth microdilution and Linezolid. His study on Microbiology is mostly dedicated to connecting different topics, such as Enterococcus faecalis. The study incorporates disciplines such as Pseudomonas aeruginosa, Enterobacteriaceae, Bacteremia and Cephalosporin in addition to Antimicrobial.

His studies deal with areas such as Klebsiella pneumoniae, Antibiotic resistance and Bacterial pneumonia as well as Staphylococcus aureus. Michael A. Pfaller combines subjects such as Tigecycline and Meropenem with his study of Broth microdilution. His Linezolid research also works with subjects such as

  • Dalbavancin, which have a strong connection to Teicoplanin, Clindamycin, Surgery and Gram,
  • Ampicillin which connect with Endocarditis,
  • Enterococcus that intertwine with fields like Oritavancin and Pediatrics.

Between 2014 and 2021, his most popular works were:

  • Manual of Clinical Microbiology, 11th Edition (175 citations)
  • Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. (138 citations)
  • Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis (87 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

His primary areas of study are Microbiology, Broth microdilution, Echinocandin, Candida glabrata and Staphylococcus aureus. The Microbiology study combines topics in areas such as Pseudomonas aeruginosa and Enterococcus faecalis. His Echinocandin research integrates issues from Voriconazole and Echinocandins.

His study looks at the intersection of Candida glabrata and topics like Anidulafungin with Candida tropicalis, Candida parapsilosis and Candida dubliniensis. Michael A. Pfaller has included themes like Haemophilus influenzae, Antibiotic resistance and Streptococcus pneumoniae in his Staphylococcus aureus study. The various areas that he examines in his Fluconazole study include Cryptococcus neoformans and Candida albicans.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Manual of clinical microbiology

Patrick R. Murray;Ellen Jo Baron;James H. Jorgensen;Marie L. Landry.
(1974)

23984 Citations

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

M. A. Pfaller;D. J. Diekema.
Clinical Microbiology Reviews (2007)

4426 Citations

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Michael B. Edmond;Sarah E. Wallace;Donna K. McClish;Michael A. Pfaller.
Clinical Infectious Diseases (1999)

2151 Citations

Attributable Mortality of Nosocomial Candidemia, Revisited

Olafur Gudlaugsson;Olafur Gudlaugsson;Shane Gillespie;Kathleen Lee;Jeff Vande Berg.
Clinical Infectious Diseases (2003)

1341 Citations

Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay

Sergio B. Wey;Motomi Mori;Michael A. Pfaller;Robert F. Woolson.
JAMA Internal Medicine (1988)

1232 Citations

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett.
Clinical Infectious Diseases (1997)

1225 Citations

RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE

J H Rex;M G Rinaldi;M A Pfaller.
Antimicrobial Agents and Chemotherapy (1995)

1127 Citations

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

David L. Horn;Dionissios Neofytos;Dionissios Neofytos;Elias J. Anaissie;Jay A. Fishman.
Clinical Infectious Diseases (2009)

1043 Citations

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.

Michael A. Pfaller.
The American Journal of Medicine (2012)

989 Citations

Epidemiology of Invasive Mycoses in North America

Michael A. Pfaller;Daniel J. Diekema.
Critical Reviews in Microbiology (2010)

941 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael A. Pfaller

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 234

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 219

Po-Ren Hsueh

Po-Ren Hsueh

National Taiwan University

Publications: 149

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 147

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 139

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 136

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 133

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 129

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 127

David R. Soll

David R. Soll

Developmental Studies Hybridoma Bank

Publications: 126

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 123

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 115

Michael G. Rinaldi

Michael G. Rinaldi

The University of Texas Health Science Center at San Antonio

Publications: 114

Maurizio Sanguinetti

Maurizio Sanguinetti

Catholic University of the Sacred Heart

Publications: 111

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 111

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 111

Trending Scientists

Aiguo Patrick Hu

Aiguo Patrick Hu

University of Auckland

Richard R. A. Syms

Richard R. A. Syms

Imperial College London

Manuel Prieto

Manuel Prieto

Instituto Superior Técnico

Jun-ichi Yamaki

Jun-ichi Yamaki

Kyushu University

Dario Pisignano

Dario Pisignano

University of Pisa

Eric Tambutté

Eric Tambutté

Scientific Centre of Monaco

Wolfgang J. Schneider

Wolfgang J. Schneider

Medical University of Vienna

Sanjay Tyagi

Sanjay Tyagi

Rutgers, The State University of New Jersey

Marco Anzidei

Marco Anzidei

National Institute of Geophysics and Volcanology

Marcel J.W. Veldhuis

Marcel J.W. Veldhuis

Apollo Vredestein

Violette Geissen

Violette Geissen

Wageningen University & Research

Angel Nuñez

Angel Nuñez

Autonomous University of Madrid

Mario Rizzetto

Mario Rizzetto

University of Turin

Howard Bergman

Howard Bergman

McGill University

Susan L. Cohn

Susan L. Cohn

University of Chicago

Silvio Waisbord

Silvio Waisbord

George Washington University

Something went wrong. Please try again later.